A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders
RESILIENCE
Randomized Clinical Trial Testing a Mixed Intervention to Improve Resilience in People Aged Over 60 Years With Neurocognitive Disorders.
1 other identifier
interventional
90
1 country
1
Brief Summary
The study aims to test a program combining cognitive behavioral therapy techniques, positive psychology techniques, mindfulness meditation and yoga, in order to improve resilience in patient with minor cognitive disorder. This intervention will be compared to a control group, but also with a group testing another intervention (an intervention that does not improve resilience in the elderly, namely a "cognitive stimulation" intervention) in order to ensure that the effect potentially obtained is not due to the simple management of the participant. The duration of the intervention will be 3 months, with an evaluation directly before and after the intervention. In addition, in order to best evaluate the effectiveness of the interventions over time, two follow-up measurements will be proposed: a measurement one month after the intervention, then a final one three months after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 30, 2025
CompletedStudy Start
First participant enrolled
April 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
May 4, 2025
May 1, 2025
2 years
January 17, 2025
May 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Improvement of resilience of patients suffering from mild neurocognitive disorder (NCD) compared to a passive control group (without any intervention).
Comparison of scores at Resilience Scale for Older Adults (RSOA) between group control and mixed intervention mixed Questionnaire adapted for older adults to evaluate resilience. The RSOA questionnaire contains 33 questions which consists of four overarching factors and 11 facets. The Intrapersonal factor consists of Perseverance and Determination, Self-Efficacy and Independence, Purpose and Meaning, and Positive Perspective. The Interpersonal factor consists of Sense of Community, Family Support, and Friend/Neighbour Support. The Spiritual factor consists of Faith and Prayer, and the Experiential factor consists of Previous Adversity and Proactivity. Each question is measured using a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree) Higher scores indicate a higher resilience.
Pre intervention
Improvement of resilience of patients suffering from mild neurocognitive disorder (NCD) compared to a passive control group (without any intervention).
Comparison of scores at Resilience Scale (RS) between group control and mixed intervention mixed The RS questionnaire contains 25 questions. The items in the resilience scale address different aspects of the ability to cope with difficulties and bounce back. For example, some statements concern the ability to find meaning in stressful situations, to remain hopeful for the future, or to feel supported by those around one. Each question is measured using a 5-point Likert scale from 1 (strongly disagree) to 7(strongly agree) Higher scores indicate a higher resilience
Pre intervention
Improvement of resilience of patients suffering from mild neurocognitive disorder (NCD) compared to a passive control group (without any intervention).
Comparison of scores at Brief-COPE between group control and mixed intervention mixed The Brief-COPE is a self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event. Coping" is defined broadly as an effort used to minimise distress associated with negative life experiences. The questionnaire contains 28 questions. Each question is measured using a 4-point Likert scale from 1 I haven't been doing this at all to 4= I've been doing this a lot Higher scores indicate a better coping.
Pre intervention
Secondary Outcomes (3)
Persistence of improvement in resilience over time
Through study completion, an average of 3 months
Persistence of improvement in resilience over time
Through study completion, an average of 3 months
Persistence of improvement in resilience over time
Through study completion, an average of 3 months
Study Arms (3)
control
NO INTERVENTIONgroup without intervention
cognitive stimulation
EXPERIMENTALgroup with 12 sessions in group of cognitive stimulation
mixed intervention
EXPERIMENTALgroup with 12 sessions in group of mixed stimulation (yoga, cognitive behavioral therapy, mindfulness meditation, positive psychology)
Interventions
12 sessions (one per week for 12 weeks) in group of cognitive stimulation
12 sessions (one per week for 12 weeks) in group of mixte stimulation (yoga, cognitive behavioral therapy, mindfullness meditation, positive psychology)
Eligibility Criteria
You may qualify if:
- Man or Woman aged \> 60 years
- Have a minor neurocognitive disorder according to the criteria of the DSM 5
- Score of 145 or less on the Wagnild and Young Resilience Scale (RS) (Wagnild, 2009).
- Subject able to read and write French;
- Subject beneficiaries of a social security scheme;
- Ability to understand and sign free and informed consent.
You may not qualify if:
- Subject already practicing meditation and/or yoga and/or Tai Chi
- Subject currently undergoing psychological therapy (whatever the approach)
- Subject with a major hearing, visual or motor disability likely to interfere with the proposed interventions or the performance of assessments;
- If taking psychotropic treatment, the dose must have been stable for 4 weeks
- Vulnerable persons are defined in Articles L1121-5 to -8
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice
Nice, 06003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SACCO GUILLAUME, Pr, MD
Centre Hospitalier Universitaire de Nice
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2025
First Posted
January 30, 2025
Study Start
April 30, 2025
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
May 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share